Continuous low-dose dexamethasone in relapsed or refractory multiple myeloma
- PMID: 11091228
- DOI: 10.1046/j.1365-2141.2000.02372.x
Continuous low-dose dexamethasone in relapsed or refractory multiple myeloma
Comment in
-
Thalidomide and low-dose dexamethasone in myeloma treatment.Br J Haematol. 2001 Jul;114(1):245. doi: 10.1046/j.1365-2141.2001.02873-5.x. Br J Haematol. 2001. PMID: 11472379 No abstract available.
Comment on
-
Therapy with thalidomide in refractory multiple myeloma patients - the revival of an old drug.Br J Haematol. 2000 Feb;108(2):391-3. doi: 10.1046/j.1365-2141.2000.01835.x. Br J Haematol. 2000. PMID: 10691870
-
CCNU (lomustine), idarubicin and dexamethasone (CIDEX): an effective oral regimen for the treatment of refractory or relapsed myeloma.Br J Haematol. 2000 Jun;109(3):571-5. doi: 10.1046/j.1365-2141.2000.02082.x. Br J Haematol. 2000. PMID: 10886206
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
